Existence Genetics | GenomeWeb

Existence Genetics

By Justin Petrone
Existence Genetics, a Los Angeles-based genetic testing company, recently introduced a new service that relies on microarray technology to screen customers for their risk for around 1,000 rare diseases.

New Releases

Premium

Existence Genetics has launched a genetic testing service that analyzes customers' risk for more than 1,000 diseases, traits, and medication reactions in a single run.

The predictive medicine company will use the Oragene DNA saliva-based collection kit.

The company's current technology is based on DNA microarray chips, but its founder and CEO said that once whole-genome sequencing becomes a routine medical procedure, its business model will change and allow the company to truly take off.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.